Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
01/11/2021 01:27
Nov 1 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* TRADING HALT-PAR.AX
* SEEKS TRADING HALT IN ORDER TO FINALISE ITS REVIEW AND
UPDATE
TO MARKET
Source text for Eikon: ID:nASX516tNY
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt